PEDIATRICS Vol. 115 No. 1 January 2005, pp. 5-9 (doi:10.1542/10.1542/peds.2004-1815)
Effect of a Probiotic Infant Formula on Infections in Child Care Centers: Comparison of Two Probiotic Agents
From the Pediatric Gastroenterology and Nutrition Unit, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel
Objective. To investigate the effect of 2 different species of probiotics in preventing infections in infants attending child care centers.
Methods. A double-blind, placebo-controlled, randomized trial was conducted from December 1, 2000, to September 30, 2002, at 14 child care centers in the Beer-Sheva area of Israel in healthy term infants 4 to 10 months old. Infants were assigned randomly to formula supplemented with Bifidobacterium lactis (BB-12), Lactobacillus reuteri (American Type Culture Collection 55730), or no probiotics. Duration of feeding, including follow-up, for each participant was 12 weeks. All infants were fed only the assigned formula and were not breastfed due to parental decision before recruitment to the study. Probiotic or prebiotic food products or supplements were not allowed. Main outcome measures were number of days and number of episodes with fever (>38°C) and number of days and number of episodes with diarrhea or respiratory illness.
Results. Participants (n = 201) were similar regarding gestational age, birth weight, gender, and previous breastfeeding. The controls (n = 60), compared with those fed B lactis (n = 73) or L reuteri (n = 68), had significantly more febrile episodes (mean [95% confidence interval]: 0.41 [0.28–0.54] vs 0.27 [0.17–0.37] vs 0.11 [0.04–0.18], respectively). The controls also had more diarrhea episodes (0.31 [0.22–0.40] vs 0.13 [0.05–0.21] vs 0.02 [0.01–0.05], respectively) and episodes of longer duration (0.59 [0.34–0.84] vs 0.37 [0.08–0.66] vs 0.15 [0.12–0.18] days, respectively). The L reuteri group, compared with BB-12 or controls, had a significant decrease of number of days with fever, clinic visits, child care absences, and antibiotic prescriptions. Rate and duration of respiratory illnesses did not differ significantly between groups.
Conclusions. Child care infants fed a formula supplemented with L reuteri or B lactis had fewer and shorter episodes of diarrhea, with no effect on respiratory illnesses. These effects were more prominent with L reuteri, which was also the only supplement to improve additional morbidity parameters.
Key Words: probiotics • infant formula • child care • infections
Abbreviations: BB-12, Bifidobacterium lactis • CFU, colony-forming units
Accepted Oct 18, 2004.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Minocha Probiotics for Preventive Health Nutr Clin Pract, April 1, 2009; 24(2): 227 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. C. Cheung, Z. Yuan, P. W Dyce, D. Wu, K. DeLange, and J. Li Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice Am. J. Clinical Nutrition, March 1, 2009; 89(3): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bukutu, C. Le, and S. Vohra Complementary, Holistic, and Integrative Medicine: The Common Cold Pediatr. Rev., December 1, 2008; 29(12): e66 - e71. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rosander, E. Connolly, and S. Roos Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L. reuteri DSM 17938 Appl. Envir. Microbiol., October 1, 2008; 74(19): 6032 - 6040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kukkonen, E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, and M. Kuitunen Long-Term Safety and Impact on Infection Rates of Postnatal Probiotic and Prebiotic (Synbiotic) Treatment: Randomized, Double-Blind, Placebo-Controlled Trial Pediatrics, July 1, 2008; 122(1): 8 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Morita, H. Toh, S. Fukuda, H. Horikawa, K. Oshima, T. Suzuki, M. Murakami, S. Hisamatsu, Y. Kato, T. Takizawa, et al. Comparative Genome Analysis of Lactobacillus reuteri and Lactobacillus fermentum Reveal a Genomic Island for Reuterin and Cobalamin Production DNA Res, June 1, 2008; 15(3): 151 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Chouraqui, D. Grathwohl, J. M. Labaune, J. M. Hascoet, I. de Montgolfier, M. Leclaire, M. Giarre, and P. Steenhout Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1365 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Whitehead, J. Versalovic, S. Roos, and R. A. Britton Genomic and Genetic Characterization of the Bile Stress Response of Probiotic Lactobacillus reuteri ATCC 55730 Appl. Envir. Microbiol., March 15, 2008; 74(6): 1812 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wall, K. Bath, R. A. Britton, H. Jonsson, J. Versalovic, and S. Roos The Early Response to Acid Shock in Lactobacillus reuteri Involves the ClpL Chaperone and a Putative Cell Wall-Altering Esterase Appl. Envir. Microbiol., June 15, 2007; 73(12): 3924 - 3935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Saavedra Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Vrese and P. R. Marteau Probiotics and Prebiotics: Effects on Diarrhea J. Nutr., March 1, 2007; 137(3): 803S - 811S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Savino, E. Pelle, E. Palumeri, R. Oggero, and R. Miniero Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study Pediatrics, January 1, 2007; 119(1): e124 - e130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J Schanler Probiotics and necrotising enterocolitis in premature infants. Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2006; 91(6): F395 - F397. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Weizman and A. Alsheikh Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study. J. Am. Coll. Nutr., October 1, 2006; 25(5): 415 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Boyle, R. M Robins-Browne, and M. L. Tang Probiotic use in clinical practice: what are the risks? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1256 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Kamiya, L Wang, P Forsythe, G Goettsche, Y Mao, Y Wang, G Tougas, and J Bienenstock Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats Gut, February 1, 2006; 55(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Journal Watch Arch. Dis. Child., May 1, 2005; 90(5): 544 - 545. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kemp Probiotic formula associated with reduced infection rate AAP News, April 1, 2005; 26(4): 2 - 2. [Full Text] [PDF]
|
|
|
|
 |
|
 Probiotics for Infants: Two Studies, Two Successes Journal Watch (General), February 11, 2005; 2005(211): 3 - 3. [Full Text]
|
|
|
|
 |
|
 Probiotics in Infants: Two Studies, Two Successes Journal Watch Pediatrics and Adolescent Medicine, February 1, 2005; 2005(201): 2 - 2. [Full Text]
|
|
|
|
|
|
C. W. Van Niel Probiotics: Not Just for Treatment Anymore Pediatrics, January 1, 2005; 115(1): 174 - 177. [Full Text] [PDF]
|
|
